News
Your contact
Gabriele Klingner
Communications & Marketing Lead
Christiane Proll
PR & Social Media Manager
News and articles from BioM about and for the Bavarian biotechnology industry.
-
Munich-based start-up Onyx Biotech secures pre-seed investment for digital, accelerated drug development20.04.2026Munich-based start-up Onyx Biotech secures pre-seed investment for digital, accelerated drug developmentThe Munich-based start-up Onyx Biotech has closed a pre-seed funding round. Investors include Life Science Valley Wachstumsfonds, Freiraum Ventures, as well as several experienced business… -
HERA plans two EU4Health tenders for May 2026: Next-generation therapeutics for infectious diseases and Filovirus investigational vaccine reserve (Marburg/Sudan Ebola)20.04.2026HERA plans two EU4Health tenders for May 2026: Next-generation therapeutics for infectious diseases and Filovirus investigational vaccine reserve (Marburg/Sudan Ebola)Under EU4Health, the European Health Emergency Preparedness and Response Authority HERA is expected to publish two calls for tenders in May 2026: Next Generation Therapeutics for Infectious… -
Bavaria strengthens pandemic preparedness: Bio<sup>M</sup> talks with high-ranking experts on resilience and biomedical preparedness14.04.2026Bavaria strengthens pandemic preparedness: BioM talks with high-ranking experts on resilience and biomedical preparednessHow can we better prepare for future pandemics and health crises? This central question was the focus of the event “Biomedical Preparedness and Health Resilience,” hosted by the Pandemic… -
Regensburg-based Evanium secures €2.2 million in seed funding14.04.2026Regensburg-based Evanium secures €2.2 million in seed fundingThe Regensburg-based company Evanium Healthcare GmbH has successfully completed a financing round with investors including FoodLabs from Berlin and Feast Ventures from Munich. The capital… -
Gain strategic clarity and a 90-day roadmap for Agentic AI: Save your early-bird rate for Bio<sup>M</sup>'s “AI4Biotech Executive Session”14.04.2026Gain strategic clarity and a 90-day roadmap for Agentic AI: Save your early-bird rate for BioM's “AI4Biotech Executive Session”Agentic AI is rapidly becoming a strategic leadership priority. To help you cut through the hype and understand what truly matters for your organization, BioM presents an exclusive full-day… -
BioFIT 2026 - get the Bio<sup>M</sup> discount13.04.2026BioFIT 2026 - get the BioM discountWe offer our network 20% discount for BioFIT 2026 on December 10 & 11, 2025 in Marseille. BioFIT is the leading partnering event in Europe for technology transfer, academia-industry… -
Tuberculosis remains a global health challenge, claiming over a million lives each year13.04.2026Tuberculosis remains a global health challenge, claiming over a million lives each yearInterview with Professor Michael Hoelscher, LMU Klinikum on Breakthroughs in Combatting Drug-Resistant Tuberculosis BioM is proud to spotlight a recent interview with Prof. Michael… -
Nanotechnology Meets Life Sciences: International Conference in Lübeck Sparks Innovation and Collaboration13.04.2026Nanotechnology Meets Life Sciences: International Conference in Lübeck Sparks Innovation and CollaborationFraunhofer IMTE is bringing together experts from the fields of nanotechnology and life sciences. The goal of the event is to strengthen interdisciplinary exchange, promote new research… -
Swiss Biotech Day 2026: Site visits and Partnering! Get your discounted ticket now!13.04.2026Swiss Biotech Day 2026: Site visits and Partnering! Get your discounted ticket now!The Swiss Biotech Day will again take place from May 4th to 5th 2026 in Basel (Switzerland). The SBD has become a premier global biotechnology conference for life sciences, offering a unique… -
Gilead acquires Munich-based biotech company and m<sup>4</sup> Award winner Tubulis for up to $5 billion07.04.2026Gilead acquires Munich-based biotech company and m4 Award winner Tubulis for up to $5 billionAmerican biopharmaceutical company Gilead Sciences, located in California, is acquiring the Munich-based biotechnology company Tubulis, thereby further expanding its oncology pipeline. The…